Standard Tigecycline Dosing in Liver Disease
Tigecycline requires dosage adjustments for patients with severe hepatic impairment. No adjustment is needed for mild to moderate liver disease (Child-Pugh A or B). For severe impairment (Child-Pugh C), the loading dose remains 100 mg, but the maintenance dose drops to 25 mg every 12 hours.[1][2]
How Liver Function Affects Tigecycline
Tigecycline undergoes extensive hepatic metabolism and biliary excretion, with about 59% of the dose eliminated via feces. Impaired liver function prolongs its half-life from 27 hours (normal) to 54 hours in severe cases, increasing exposure and risk of adverse effects like nausea or elevated liver enzymes. Pharmacokinetic studies confirm higher AUC (area under the curve) in Child-Pugh C patients, justifying the reduced dose.[1][3]
Dosing by Severity Level
| Hepatic Impairment | Loading Dose | Maintenance Dose | Notes |
|--------------------|--------------|------------------|-------|
| None/Mild/Moderate (Child-Pugh A/B) | 100 mg | 50 mg IV q12h | Standard regimen |
| Severe (Child-Pugh C) | 100 mg | 25 mg IV q12h | Monitor closely; data limited in end-stage liver disease |
| ESRD on Hemodialysis | No adjustment | No adjustment | Primarily hepatic clearance, not significantly dialyzable |
End-stage renal disease does not require adjustment since clearance is hepatic-dominant.[1][2]
Monitoring and Risks in Liver Patients
Watch for overexposure signs like gastrointestinal upset or superinfections. Tigecycline carries a black box warning for increased mortality risk in certain infections, amplified in vulnerable liver patients. Baseline and periodic liver function tests are advised, especially with ongoing use.[1][4]
Alternatives if Adjustment Isn't Feasible
For severe liver disease, options include beta-lactams (e.g., piperacillin-tazobactam) or carbapenems (e.g., meropenem), which rely less on hepatic clearance. Consult infectious disease specialists for multidrug-resistant infections where tigecycline is typically used.[4]
[1]: Tygacil (tigecycline) Prescribing Information
[2]: Drugs.com - Tigecycline Dosage Guide
[3]: Muralidharan G et al. Pharmacokinetics of tigecycline in subjects with hepatic impairment. Antimicrob Agents Chemother. 2005;49(4):1739-1742. PubMed
[4]: Lexicomp - Tigecycline Monograph (UpToDate/Wolters Kluwer)